Professional
Added to YB: 2026-04-01
Pitch date: 2026-01-17
TMO [neutral]
Thermo Fisher Scientific Inc.
-19.28%
current return
Author Info
No bio for this author
Company Info
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
Market Cap
$175.8B
Pitch Price
$608.90
Price Target
N/A
Dividend
0.36%
EV/EBITDA
17.87
P/E
26.68
EV/Sales
4.65
Sector
Life Sciences Tools and Services
Category
growth
Bristol Gate US Equity Strategy Portfolio Holding: Thermo Fisher Scientific Inc.
TMO (holding update): Q3 beat drove rally to new 52W high. Pharma clients more confident navigating US policy, planning capacity expansions benefiting TMO equipment sales & CDMO network. Growth expected to build through 2026, exiting at 3-6% organic revenue run rate (long-term target) as headwinds abate.
Read full article (1 min)